E
Ultragenyx Pharmaceutical Inc. RARE
$39.34 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -133.39M -133.52M -131.60M -170.68M -123.19M
Total Depreciation and Amortization 9.08M 8.76M 8.86M 8.85M 8.22M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 22.05M 26.94M 29.42M 27.13M 17.76M
Change in Net Operating Assets 22.75M 30.83M 16.36M -56.02M 13.30M
Cash from Operations -79.50M -67.00M -76.96M -190.73M -83.90M
Capital Expenditure -654.00K -1.62M -2.01M -3.21M -1.60M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 103.39M -273.89M 62.57M 97.65M -105.42M
Cash from Investing 102.74M -275.50M 60.56M 94.44M -107.02M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 3.19M 4.17M 384.88M -- 330.61M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 0.00 7.00M 58.00K -58.00K 0.00
Cash from Financing 3.19M 11.17M 384.94M -58.00K 330.61M
Foreign Exchange rate Adjustments -2.47M 1.28M -648.00K -679.00K 1.10M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 23.95M -330.05M 367.89M -97.03M 140.79M
Weiss Ratings